Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation

Transplantation. 2011 Mar 15;91(5):e29-30. doi: 10.1097/TP.0b013e318208138c.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Grouping and Crossmatching*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Female
  • Graft Rejection / epidemiology*
  • Graft Rejection / immunology*
  • Graft Rejection / prevention & control
  • Humans
  • Immunity, Humoral / immunology*
  • Incidence
  • Infant
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Plasmapheresis
  • Protease Inhibitors / therapeutic use
  • Pyrazines / therapeutic use
  • Retrospective Studies

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib